Page last updated: 2024-09-03

imatinib mesylate and HTLV-I Infections

imatinib mesylate has been researched along with HTLV-I Infections in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Au, WY; Chan, E; Lie, AK	1

Other Studies

1 other study(ies) available for imatinib mesylate and HTLV-I Infections

Article	Year
Hemopoietic stem cell transplantation from a donor with indeterminate HTLV-1 status. American journal of hematology, 2007, Volume: 82, Issue:6 Topics: Adult; Antineoplastic Agents; Benzamides; Blotting, Western; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Imatinib Mesylate; Piperazines; Polymerase Chain Reaction; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Recurrence; Remission Induction; Risk Factors; Tissue Donors; Treatment Outcome	2007

Article

Year

Hemopoietic stem cell transplantation from a donor with indeterminate HTLV-1 status.

American journal of hematology, 2007, Volume: 82, Issue:6

Topics: Adult; Antineoplastic Agents; Benzamides; Blotting, Western; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Imatinib Mesylate; Piperazines; Polymerase Chain Reaction; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Recurrence; Remission Induction; Risk Factors; Tissue Donors; Treatment Outcome

2007